
|Articles|April 22, 2008
Colesevelam now included in ACE/AACE guide as combination therapy for glycemic control
Bile sequestrant colesevelam now included in endocrinologist groups' diabetes guide.
Advertisement
The American College of Endocrinologists (ACE) and the American Association of Endocrinologists (AACE) have included colesevelam (Welchol, Daiichi Sankyo), a bile acid sequestrant, as an option for treating patients with Type 2 diabetes in their Road Maps to Achieve Glycemic Control in
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Providers, Patients Show Favorable Perception of Remdesivir During COVID-19 Pandemic
2
PCV21 Shows Cost Effectiveness Compared With PCV15, PCV13, and PPSV23
3
Lower Baseline BMI Predicts Weight Loss At 6 Months With Liraglutide
4


























































































































































